Identification of the xenograft and its ascendant sphere-forming cell line as belonging to EBV-induced lymphoma, and characterization of the status of sphere-forming cells

Evgeniya V. Dolgova, Daria D. Petrova, Anastasia S. Proskurina, Genrikh S. Ritter, Polina E. Kisaretova, Ekaterina A. Potter, Yaroslav R. Efremov, Sergey I. Bayborodin, Tatiana V. Karamysheva, Margarita V. Romanenko, Sergey V. Netesov, Oleg S. Taranov, Aleksandr A. Ostanin, Elena R. Chernykh, Sergey S. Bogachev

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)

Abstract

Background: We have characterized the human cell line arised from the Epstein-Barr virus (EBV) positive multiple myeloma aspirate subjected to the long-term cultivation. This cell line has acquired the ability to form free-floating spheres and to produce a xenograft upon transplantation into NOD/SCID mice. Methods: Cells from both in vitro culture and developed xenografts were investigated with a number of analytical approaches, including pathomorphological analysis, FISH analysis, and analysis of the surface antigens and of the VDJ locus rearrangement. Results: The obtained results, as well as the confirmed presence of EBV, testify that both biological systems are derived from B-cells, which, in turn, is a progeny of the EBV-transformed B-cellular clone that supplanted the primordial multiple myeloma cells. Next we assessed whether cells that (i) were constantly present in vitro in the investigated cell line, (ii) were among the sphere-forming cells, and (iii) were capable of internalizing a fluorescent TAMRA-labeled DNA probe (TAMRA+ cells) belonged to one of the three types of undifferentiated bone marrow cells of a multiple myeloma patient: CD34+ hematopoietic stem cells, CD90+ mesenchymal stem cells, and clonotypic multiple myeloma cell. Conclusion: TAMRA+ cells were shown to constitute the fourth independent subpopulation of undifferentiated bone marrow cells of the multiple myeloma patient. We have demonstrated the formation of ectopic contacts between TAMRA+ cells and cells of other types in culture, in particular with CD90+ mesenchymal stem cells, followed by the transfer of some TAMRA+ cell material into the contacted cell.

Original languageEnglish
Article number120
Pages (from-to)120
Number of pages21
JournalCancer Cell International
Volume19
Issue number1
DOIs
Publication statusPublished - 6 May 2019

Keywords

  • B-cell lymphoma
  • Clonotypic B cell
  • Lymphoblastoid cell line
  • Mesenchymal stem cells
  • TAMRA-labeled DNA probe
  • CANCER-CELLS
  • MULTIPLE-MYELOMA
  • DEEP-SEQUENCING METHOD
  • FUSION
  • ACUTE MYELOID-LEUKEMIA
  • PROGNOSTIC VALUE
  • MESENCHYMAL STEM-CELLS
  • IN-VITRO
  • DISEASE
  • EXPRESSION

Fingerprint

Dive into the research topics of 'Identification of the xenograft and its ascendant sphere-forming cell line as belonging to EBV-induced lymphoma, and characterization of the status of sphere-forming cells'. Together they form a unique fingerprint.

Cite this